XXXX : a new antiarrhythmic drug.

@entity1 @entity227 @entity712 @entity713 @entity6237 @entity591 @entity1817 @entity5036 @entity943
@entity6237 is a new class 1 c antiarrhythmic drug. It slows conduction in the working myocardium and the specialized conduction system and may depress sinus node activity in @entity1 with pre-existing @entity1817 . Its hemodynamic effects are minimal. The drug is completely absorbed and shows a half-life of 7-22 hours. Elimination is mainly through the kidneys. @entity6237 is highly effective in the treatment of @entity943 , @entity591 . Side effects are mild and consist mostly of dizziness, @entity227 , and nervousness. They rarely require discontinuation of therapy. Proarrhythmic effects have been reported. Caution is required in @entity1 with @entity712 , @entity713 , and/or @entity5036 .
